Early pregnancy loss in women stimulated with gonadotropin-releasing hormone antagonist protocols according to oral contraceptive pill pretreatment

Fertil Steril. 2007 May;87(5):1098-101. doi: 10.1016/j.fertnstert.2006.08.098. Epub 2007 Jan 16.

Abstract

Objective: To evaluate and compare the risk of early pregnancy loss in patients stimulated with GnRH antagonist protocols according to oral contraceptive pill (OCP) pretreatment.

Design: Retrospective case-control study.

Setting: Instituto Valenciano de Infertilidad. University of Valencia. Spain.

Patient(s): One thousand five hundred thirty-nine patients, aged <36, stimulated with GnRH antagonists for IVF between January 1, 2000 and November 1, 2005.

Intervention(s): Reproductive outcome was compared based on the application (or not) of OCP pretreatment: 944 women were included in the OCP group and 595 in the non-OCP group. The Student's t test was used for statistics.

Main outcome measure(s): Pregnancy, biochemical pregnancy, ectopic pregnancy, early clinical pregnancy loss, early pregnancy loss, and ongoing pregnancy rates.

Result(s): No significant differences were observed in any of the outcome parameters. Early pregnancy loss rates were similar: 23% in the OCP pretreatment group versus 19.2% in the non-OCP pretreatment group. However, longer periods of ovarian stimulation and higher doses of gonadotropins needed to be employed in the OCP group.

Conclusion(s): There is not sufficient evidence to confirm OCP pretreatment as a risk factor for miscarriage in patients stimulated with GnRH antagonist protocols.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Case-Control Studies
  • Contraceptives, Oral / administration & dosage*
  • Contraceptives, Oral / adverse effects
  • Embryo Loss / chemically induced
  • Embryo Loss / epidemiology*
  • Female
  • Gonadotropin-Releasing Hormone / antagonists & inhibitors*
  • Gonadotropin-Releasing Hormone / physiology
  • Humans
  • Pregnancy
  • Pregnancy Rate
  • Retrospective Studies

Substances

  • Contraceptives, Oral
  • Gonadotropin-Releasing Hormone